Search Results - Richard D. Carvajal

Refine Results
  1. 1
    KIT as a Therapeutic Target in Metastatic Melanoma

    KIT as a Therapeutic Target in Metastatic Melanoma by Richard D. Carvajal

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Tebentafusp for the treatment of HLA-A*02:01–positive adult patients with unresectable or metastatic uveal melanoma

    Tebentafusp for the treatment of HLA-A*02:01–positive adult patients with unresectable or metastatic uveal melanoma by Lanyi Nora Chen, Richard D. Carvajal

    Published 2022
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Aurora Kinases: New Targets for Cancer Therapy

    Aurora Kinases: New Targets for Cancer Therapy by Richard D. Carvajal, Archie Tse, Gary K. Schwartz

    Published 2006
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Targeting Checkpoint Kinase 1 in Cancer Therapeutics

    Targeting Checkpoint Kinase 1 in Cancer Therapeutics by Archie Tse, Richard D. Carvajal, Gary K. Schwartz

    Published 2007
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Mucosal Melanoma: A Clinically and Biologically Unique Disease Entity

    Mucosal Melanoma: A Clinically and Biologically Unique Disease Entity by Richard D. Carvajal, Sharon A. Spencer, William M. Lydiatt

    Published 2012
    Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Tebentafusp: T Cell Redirection for the Treatment of Metastatic Uveal Melanoma

    Tebentafusp: T Cell Redirection for the Treatment of Metastatic Uveal Melanoma by Bertil Damato, Joseph Dukes, Howard Goodall, Richard D. Carvajal

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Uveal Melanoma Exosomes Induce a Prometastatic Microenvironment through Macrophage Migration Inhibitory Factor

    Uveal Melanoma Exosomes Induce a Prometastatic Microenvironment through Macrophage Migration Inhibitory Factor by Grazia Ambrosini, J. Alex, Richard D. Carvajal, Gary K. Schwartz

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Ipilimumab in patients with melanoma and autoimmune disease

    Ipilimumab in patients with melanoma and autoimmune disease by Chrisann Kyi, Richard D. Carvajal, Jedd D. Wolchok, Michael A. Postow

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Treatment of uveal melanoma: where are we now?

    Treatment of uveal melanoma: where are we now? by Jessica Yang, Daniel K. Manson, Brian P. Marr, Richard D. Carvajal

    Published 2018
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    Kinetics of RTK activation determine ERK reactivation and resistance to dual BRAF/MEK inhibition in melanoma

    Kinetics of RTK activation determine ERK reactivation and resistance to dual BRAF/MEK inhibition in melanoma by Sung Soo Kim, Richard D. Carvajal, Minah Kim, Hee Won Yang

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer

    Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer by Omid Hamid, Brianna Hoffner, Eduard Gasal, Jenny J. Hong, Richard D. Carvajal

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  12. 12
    Sarcoma Immunotherapy: Past Approaches and Future Directions

    Sarcoma Immunotherapy: Past Approaches and Future Directions by Sandra P. D’Angelo, William D. Tap, Gary K. Schwartz, Richard D. Carvajal

    Published 2014
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  13. 13
    Efficacy, Safety, and Tolerability of Approved Combination BRAF and MEK Inhibitor Regimens for BRAF-Mutant Melanoma

    Efficacy, Safety, and Tolerability of Approved Combination BRAF and MEK Inhibitor Regimens for BRAF-Mutant Melanoma by Omid Hamid, C. Lance Cowey, M Offner, Mark B. Faries, Richard D. Carvajal

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Study design and rationale for a randomised, placebo-controlled, double-blind study to assess the efficacy of selumetinib (AZD6244; ARRY-142886) in combination with dacarbazine in patients with metastatic uveal melanoma (SUMIT)

    Study design and rationale for a randomised, placebo-controlled, double-blind study to assess the efficacy of selumetinib (AZD6244; ARRY-142886) in combination with dacarbazine in... by Richard D. Carvajal, Gary K. Schwartz, Helen Mann, Ian C. P. Smith, Paul Nathan

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Uveal melanoma: epidemiology, etiology, and treatment of primary disease

    Uveal melanoma: epidemiology, etiology, and treatment of primary disease by Benjamin A. Krantz, Nikita Dave, Kimberly M. Komatsubara, Brian P. Marr, Richard D. Carvajal

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  16. 16
    Arginine depletion as a therapeutic approach for patients with COVID-19

    Arginine depletion as a therapeutic approach for patients with COVID-19 by Joseph M. Grimes, Shaheer Khan, Mark Badeaux, Ravi M. Rao, Scott W. Rowlinson, Richard D. Carvajal

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  17. 17
    Safety and efficacy of ipilimumab to treat advanced melanoma in the setting of liver transplantation

    Safety and efficacy of ipilimumab to treat advanced melanoma in the setting of liver transplantation by Rita E Morales, Alexander N. Shoushtari, Michelle M. Walsh, Priya Grewal, Evan J. Lipson, Richard D. Carvajal

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    A Phase I Clinical Trial of Safingol in Combination with Cisplatin in Advanced Solid Tumors

    A Phase I Clinical Trial of Safingol in Combination with Cisplatin in Advanced Solid Tumors by Mark A. Dickson, Richard D. Carvajal, Alfred H. Merrill, Mithat Gönen, Lauren M. Cane, Gary K. Schwartz

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Metastatic disease from uveal melanoma: treatment options and future prospects

    Metastatic disease from uveal melanoma: treatment options and future prospects by Richard D. Carvajal, Gary K. Schwartz, Tongalp H. Tezel, Brian P. Marr, Jasmine H. Francis, Paul Nathan

    Published 2016
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  20. 20
    Identification of Unique MEK-Dependent Genes in GNAQ Mutant Uveal Melanoma Involved in Cell Growth, Tumor Cell Invasion, and MEK Resistance

    Identification of Unique MEK-Dependent Genes in GNAQ Mutant Uveal Melanoma Involved in Cell Growth, Tumor Cell Invasion, and MEK Resistance by Grazia Ambrosini, Christine A. Pratilas, Li-Xuan Qin, Madhavi Tadi, Oliver Surriga, Richard D. Carvajal, Gary K. Schwartz

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: